PMP Awareness - research

PMP Awareness Organization

RESEARCH

HOME ::

RESEARCH - Abstracts

We hope this collective research helps others digging for much needed information. If you have an abstract you would like to add, please let us know.

Abstracts of interest: 1995-2009 (most recent documents are listed first)

Diffusion-Weighted MRI of Peritoneal Tumors: Comparison With Conventional MRI and Surgical and Histopathologic Findings—A Feasibility Study
Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve.
Safety of Gastric Resections During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis
Long-Term Survival in Patients with Pseudomyxoma Peritonei Treated with Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: 10 Years of Experience from a Single Institution
Malignant primary peritoneal tumors
Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy
Thoracic cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy for pseudomyxoma peritonei
Management of mucinous urachal neoplasm presenting as pseudomyxoma peritonei
Adenocarcinoma of the Appendix Is Rarely Detected by Colonoscopy
Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei)
Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Quality of Life After Cytoreductive Surgery plus Early Intraperitoneal Postoperative Chemotherapy for Pseudomyxoma Peritonei: A Prospective Study
Updated treatment of peritoneal carcinomas: a review
Swedish Experience with Peritonectomy and HIPEC. HIPEC in Peritoneal Carcinomatosis
Peritoneal carcinomatosis. Ten years of applying the new combined triple therapy. Personal experience
Pseudomyxoma Peritonei: Clinical Pathological and Biological Prognostic Factors in Patients Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Learning curve of combined modality treatment in peritoneal surface disease
Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary.
Prognostic Value of Circulating Tumor Markers in Patients with Pseudomyxoma Peritonei Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
The results of surgical treatment for pseudomyxoma peritonei
The diagnostic value of PET-CT for peritoneal dissemination of abdominal malignancies
Cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy (HIPEC) in the treatment of pseudomyxoma peritonei: ten years experience in a single center.
Early Results of Surgery in 123 Patients with Pseudomyxoma Peritonei from a Perforated Appendiceal Neoplasm
Progression of Pseudomyxoma Peritonei after Combined Modality Treatment: Management and Outcome
A Systematic Review on the Efficacy of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei
Analysis of Loss of Heterozygosity for Tumor-Suppressor Genes Can Accurately Classify and Predict the Clinical Behavior of Mucinous Tumors Arising From the Appendix
Clinical practice guideline on peritoneal carcinomatosis treatment using surgical cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy
CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases
Cytokeratins 7 and 20 in primary and secondary mucinous tumors of the ovary: analysis of coordinate immunohistochemical expression profiles and staining distribution in 179 cases.
Hyperthermic intraperitoneal chemotherapy and cytoreductive surgery for peritoneal carcinomatosis of colorectal origin: a novel treatment strategy with promising results in selected patients
Cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal mucinous neoplasms
Cytoreductive surgery followed by intra peritoneal hyperthermic perfusion in the treatment of peritoneal surface malignancies: morbidity and mortality with closed abdomen technique.
An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with pseudomyxoma peritonei.
Pseudomyxoma peritonei arising from colonic polyps
MRI evaluation of bulky tumor masses in the mesentery and bladder involvement in peritoneal carcinomatosis.
Splenic metastases from mucinous neoplasms of the appendix and colon
Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review.
Review of patients with peritoneal malignancy treated with peritonectomy and heated intraperitoneal chemotherapy.
Recurrence of pseudomyxoma peritonei within the inguinal canal
COX-2 expression in pseudomyxoma peritonei.
Pseudomyxoma peritonei and the urinary tract: Involvement and treatment related complications
Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei—a report of 103 procedures
Operability and early outcome in 100 consecutive laparotomies for peritoneal malignancy
Bowel complications in 203 cases of peritoneal surface malignancies treated with peritonectomy and closed-technique intraperitoneal hyperthermic perfusion.
Treatment of peritoneal surface malignancy by peritonectomy and intraperitoneal chemotherapy: a novel therapy with curative potential!
Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence
Cytoreductive Surgery With Intraperitoneal Chemohyperthermia for the Treatment of Pseudomyxoma Peritonei: A Prospective Study
Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix
Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior
Peritonectomy and Intraperitoneal Hyperthermic Perfusion (IPHP): A Strategy That Has Confirmed its Efficacy in Patients with Pseudomyxoma Peritonei
Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia.
Clinically aggressive pseudomyxoma peritonei: A variant of a histologically indolent process
The etiology, clinical presentation, and management of pseudomyxoma peritonei
Phase I clinical and pharmacological study of intraperitoneal cis-bis-neodecanoato(trans-R, R-1, 2-diaminocyclohexane)-platinum II entrapped in multilamellar liposome vesicles
Treatment of pseudomyxoma peritonei using cytoreduction and intraperitoneal hyperthermic chemotherapy
Intraperitoneal cancer dissemination: Mechanisms of the patterns of spread
Heat penetration in locally applied hyperthermia in the abdomen during intra-operative hyperthermic intraperitoneal chemotherapy
Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei.
Feasibility of peritonectomy associated with intraperitoneal hyperthermic perfusion in patients with Pseudomyxoma peritonei.
Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy
Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas.
Pathology of borderline (low malignant potential) ovarian tumours
The subpyloric space: an important surgical and radiologic feature in pseudomyxoma peritonei
CT in pseudomyxoma peritonei: a review of 17 cases
Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy
Cytoreduction including total gastrectomy for pseudomyxoma peritonei
Pedunculated peritoneal surface polyps in pseudomyxoma peritonei syndrome
Molecular genetic analysis of appendiceal mucinous adenomas in identical twins, including one with pseudomyxoma peritonei
CT appearance of disseminated peritoneal adenomucinosis.
Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome
Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei
Pseudomyxoma peritonei in a hernia sac: analysis of 20 patients in whom mucoid fluid was found during a hernia repair
Unusual origins of Pseudomyxoma peritonei
Adult respiratory distress syndrome occurring in two patients undergoing cytoreductive surgery plus perioperative intraperitoneal chemotherapy: case reports and a review of the literature.
Clinical presentation of the Pseudomyxoma peritonei syndrome
Hemodynamic and cardiac function parameters during heated intraoperative intraperitoneal chemotherapy using the open "coliseum technique".
Pleural extension of mucinous tumor in patients with pseudomyxoma peritonei syndrome
Congenital pleuroperitoneal communication in a patient with pseudomyxoma peritonei
Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy
Hyperthermic intra-peritoneal chemotherapy (HIPEC) in patients with peritoneal pseudomyxoma or peritoneal metastases of colorectal carcinoma; good preliminary results from the Netherlands Cancer Institute
Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas.
Pulmonary metastases in pseudomyxoma peritonei syndrome
Pseudomyxoma peritonei: new concepts in diagnosis, origin, nomenclature, and relationship to mucinous borderline (low malignant potential) tumors of the ovary
Immunohistochemical evidence supporting the appendiceal origin of pseudomyxoma peritonei in women
Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin
Clinical determinants of treatment failure in patients with pseudomyxoma peritonei
Pseudomyxoma peritonei
Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei".
Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potential